Back to News
Market Impact: 0.15
Vasomune Therapeutics Receives Funding Assistance to Advance Its Dual-Use Vascular Leak Therapy
Source: Business Wire
Healthcare & BiotechProduct LaunchesTechnology & Innovation
Vasomune received up to C$280,347 from NRC IRAP to develop a subcutaneous formulation of its investigational vascular leak therapy, Pegevongitide. The funding supports development; the article provides no clinical results or commercialization timeline.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Samsung, SK Hynix shares drop as Q3 earnings loom
- DeepSeek set to raise at least $12 bln in Tencent, CATL-led round- Bloomberg
- Security researcher claims to they found KVM guest-host escape flaw
- OKX debuts a platform that turns 50 currencies into digital dollars, betting emerging market investors want stablecoins
- Brazil Election: Bolsonaro Pushes Lula to Brink as Markets Set to Rally
- SpaceX stock climbs to highest since June, returning Musk to trillionaire status
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How to Evaluate Consensus Estimates Platforms With AI
- Weekly Update: Adding Live MBO Level 3 Data - Liquidity Heatmap, OFI Charts, and More